Globus Medical Inc(GMED)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GMED Globus Medical Inc

盘前交易 03-24 08:16:14 EDT

87.21

+0.95

+1.10%

盘前86.70

-0.51-0.58%

07:10 EDT

最高88.36	最低86.84	成交量77.60万
今开87.63	昨收86.26	日振幅1.76%
总市值117.73亿	流通市值97.44亿	总股本1.35亿
成交额6,792万	换手率0.69%	流通股本1.12亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GMED","market":"US","secType":"STK","nameCN":"Globus Medical Inc","latestPrice":87.21,"timestamp":1774296000000,"preClose":86.26,"halted":0,"volume":776048,"hourTrading":{"tag":"盘前","latestPrice":86.7,"preClose":87.21,"latestTime":"07:10 EDT","volume":4,"amount":347.639984,"timestamp":1774350629399,"change":-0.51,"changeRate":-0.005848,"amplitude":0.006421},"delay":0,"changeRate":0.011013215859030704,"floatShares":111729713,"shares":135000000,"eps":3.92,"marketStatus":"盘前交易","change":0.95,"latestTime":"03-24 08:16:14 EDT","open":87.63,"high":88.36,"low":86.8403,"amount":67916799.13927999,"amplitude":0.017618,"askPrice":87.5,"askSize":1,"bidPrice":83.8,"bidSize":24,"shortable":3,"etf":0,"ttmEps":3.92,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774359000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1343966400000,"exchange":"NYSE","adjPreClose":87.21,"preHourTrading":{"tag":"盘前","latestPrice":86.7,"preClose":87.21,"latestTime":"07:10 EDT","volume":4,"amount":347.639984,"timestamp":1774350629399,"change":-0.51,"changeRate":-0.005848,"amplitude":0.006421},"postHourTrading":{"tag":"盘后","latestPrice":87.21,"preClose":87.21,"latestTime":"18:53 EDT","volume":16541,"amount":1442541.6844,"timestamp":1774306386927,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7482447226482147,"impliedVol":0.3969,"impliedVolPercentile":0.624},"requestUrl":"/m/hq/s/GMED","defaultTab":"news","newsList":[{"id":"1197148119","title":"财报前瞻｜Globus Medical Inc本季度营收预计增24.21%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1197148119","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197148119?lang=zh_cn&edition=full","pubTime":"2026-02-17 10:50","pubTimestamp":1771296655,"startTime":"0","endTime":"0","summary":"Globus Medical Inc将于2026年02月24日发布最新季度财报，市场关注营收与每股收益的同比增长以及利润率延续性。市场一致预测显示，Globus Medical Inc本季度营收预计为7.99亿USD，同比增24.21%；调整后每股收益预计为1.15USD，同比增54.19%；息税前利润预计为2.07亿USD，同比增57.68%。上季度，Globus Medical Inc实现营收7.69亿USD，同比增长22.91%；毛利率为68.00%；归属于母公司股东的净利润为1.19亿USD；净利率为15.47%；调整后每股收益为1.18USD，同比增长42.17%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Globus Medical Inc本季度营收预计增24.21%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GMED"],"gpt_icon":0},{"id":"1196966779","title":"Nuvama财富管理公司公布12月季度合并净利润25.4亿卢比","url":"https://stock-news.laohu8.com/highlight/detail?id=1196966779","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196966779?lang=zh_cn&edition=full","pubTime":"2026-01-23 20:44","pubTimestamp":1769172280,"startTime":"0","endTime":"0","summary":"Nuvama财富管理有限公司最新财报显示，该公司在12月季度实现合并净利润25.4亿卢比。同期，其合并营业收入达到110.4亿卢比。\n此外，该公司宣布将通过认购Nuvama资产管理公司股份的方式投资10亿卢比。这一战略投资将进一步加强公司在资产管理领域的布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","IE0009354923.USD","GMED","LU2065732104.USD"],"gpt_icon":0},{"id":"1120267270","title":"异动解读 | Globus Medical盘前大涨31.10%,多家券商上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1120267270","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120267270?lang=zh_cn&edition=full","pubTime":"2025-11-07 22:37","pubTimestamp":1762526252,"startTime":"0","endTime":"0","summary":"周五盘前，医疗器械公司Globus Medical股价大幅上涨31.10%，引发市场广泛关注。这一显著涨幅主要源于公司发布强劲的第三季度财报以及多家知名券商上调对该公司的评级和目标价。多家知名券商随即上调了对Globus Medical的评级和目标价。更值得注意的是，Truist Securities将Globus Medical的评级从\"持有\"上调至\"买入\"，并将目标价从65美元大幅上调至93美元，上调幅度高达43%。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GMED"],"gpt_icon":0},{"id":"2513724117","title":"巴克莱：维持Globus Medical(GMED.US)评级，由增持调整至增持评级, 目标价由100.00美元调整至103.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513724117","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513724117?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:13","pubTimestamp":1740406420,"startTime":"0","endTime":"0","summary":"巴克莱：维持Globus Medical(GMED.US)评级，由增持调整至增持评级, 目标价由100.00美元调整至103.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24221348352761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GMED"],"gpt_icon":0},{"id":"2513756135","title":"Globus Medical, Inc.2024财年实现净利润1.03亿美元，同比减少16.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513756135","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513756135?lang=zh_cn&edition=full","pubTime":"2025-02-24 00:01","pubTimestamp":1740326492,"startTime":"0","endTime":"0","summary":"2月24日，Globus Medical, Inc.公布财报，公告显示公司2024财年净利润为1.03亿美元，同比减少16.26%；其中营业收入为25.19亿美元，同比增加60.65%，每股基本收益为0.76美元。从资产负债表来看，Globus Medical, Inc.总负债10.74亿美元，其中短期债务4.54亿美元，资产负债比为4.90，流动比率为2.55。机构评级：截至2025年2月24日，当前有13家机构对Globus Medical, Inc.目标价做出预测，其中目标均价为98.69美元，其中最低目标价为90.00美元，最高目标价为115.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000221a250ce41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000221a250ce41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GMED"],"gpt_icon":0},{"id":"2513135612","title":"Globus Medical, Inc.盘中异动 急速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513135612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513135612?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:29","pubTimestamp":1740158998,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时29分，Globus Medical, Inc.股票出现异动，股价急速下跌5.08%。Globus Medical, Inc.股票所在的医疗器械行业中，整体跌幅为0.27%。其相关个股中，Ainos Inc C/Wts 29/07/2027 、Sintx Technologies, Inc.、Intelligent Bio Solutions Inc.涨幅较大，Sintx Technologies, Inc.、Reshape Lifesciences, Inc.、沃氪医疗较为活跃，换手率分别为189.92%、42.27%、20.24%，振幅较大的相关个股有Ainos Inc C/Wts 29/07/2027 、Pavmed Inc C/Wts 30/04/2025 Class Z、Nexalin Technology Inc C/Wts ，振幅分别为89.61%、59.52%、30.77%。Globus Medical, Inc.公司简介：Globus Medical Inc是一家医疗设备公司，为医院、医生和外科中心开发并提供医疗保健产品和解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222012958962ba2c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222012958962ba2c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","LU2065732104.USD","IE0009354923.USD","GMED"],"gpt_icon":0},{"id":"2513529626","title":"Stifel：维持Globus Medical(GMED.US)评级，由买入调整至买入评级, 目标价由92.00美元调整至94.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513529626","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513529626?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:41","pubTimestamp":1740148867,"startTime":"0","endTime":"0","summary":"Stifel：维持Globus Medical(GMED.US)评级，由买入调整至买入评级, 目标价由92.00美元调整至94.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/21224148320217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GMED"],"gpt_icon":0},{"id":"2513642212","title":"Needham：重申Globus Medical(GMED.US)评级，由持有调整至持有评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513642212","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513642212?lang=zh_cn&edition=full","pubTime":"2025-02-21 20:27","pubTimestamp":1740140875,"startTime":"0","endTime":"0","summary":"Needham：重申Globus Medical(GMED.US)评级，由持有调整至持有评级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/21202748318257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GMED"],"gpt_icon":0},{"id":"1113698346","title":"Globus Medical 2024年第四季度每股收益$0.84超出预期$0.75，销售额$6.5729亿超出预期$6.4179亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1113698346","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113698346?lang=zh_cn&edition=full","pubTime":"2025-02-21 05:18","pubTimestamp":1740086330,"startTime":"0","endTime":"0","summary":"Globus Medical  报告季度每股收益为$0.84，超出分析师普遍预期的$0.75，超出12%。该公司报告季度销售额为$6.5729亿，超出分析师普遍预期的$6.4179亿，超出2.42%。与去年同期销售额$6.1653亿相比增长了6.61%。以上内容来自Benzinga Earnings专栏，原文如下：Globus Medical  reported quarterly earnings of $0.84 per share which beat the analyst consensus estimate of $0.75 by 12 percent. This is a 40 percent increase over earnings of $0.60 per share from the same period last year.  The company reported quarterly sales of $657.29 million which beat the analyst consensus estimate of $641.79 million ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Globus Medical 2024年第四季度每股收益$0.84超出预期$0.75，销售额$6.5729亿超出预期$6.4179亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GMED"],"gpt_icon":0},{"id":"2509272526","title":"Globus Medical, Inc.盘中异动 股价大跌5.23%报87.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509272526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509272526?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:31","pubTimestamp":1738852292,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时31分，Globus Medical, Inc.股票出现波动，股价急速下挫5.23%。截至发稿，该股报87.57美元/股，成交量3.8505万股，换手率0.03%，振幅2.37%。Globus Medical, Inc.股票所在的医疗器械行业中，整体跌幅为0.12%。Globus Medical, Inc.公司简介：Globus Medical Inc是一家医疗设备公司，为医院、医生和外科中心开发并提供医疗保健产品和解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223133a23bce20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223133a23bce20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","IE0009354923.USD","LU2065732104.USD","GMED"],"gpt_icon":0},{"id":"2502447893","title":"加拿大投资银行集团：维持Globus Medical(GMED.US)评级，由买入调整至买入评级, 目标价由92.00美元调整至101.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2502447893","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502447893?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:33","pubTimestamp":1736523183,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团：维持Globus Medical(GMED.US)评级，由买入调整至买入评级, 目标价由92.00美元调整至101.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/10233347360005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GMED"],"gpt_icon":0},{"id":"2502010979","title":"B of A Securities：上调Globus Medical(GMED.US)评级，由低于大市调整至中性评级, 目标价由80.00美元调整至97.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2502010979","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502010979?lang=zh_cn&edition=full","pubTime":"2025-01-09 22:02","pubTimestamp":1736431341,"startTime":"0","endTime":"0","summary":"B of A Securities：上调Globus Medical(GMED.US)评级，由低于大市调整至中性评级, 目标价由80.00美元调整至97.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/09220247318816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GMED"],"gpt_icon":0},{"id":"2482267891","title":"Globus Medical, Inc.2024财年第三财季实现净利润51.84百万美元，同比增加5094.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482267891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482267891?lang=zh_cn&edition=full","pubTime":"2024-11-11 00:01","pubTimestamp":1731254509,"startTime":"0","endTime":"0","summary":"11月11日，Globus Medical, Inc.公布财报，公告显示公司2024财年第三财季净利润为51.84百万美元，同比增加5094.39%；其中营业收入为6.26亿美元，同比增加63.02%，每股基本收益为0.38美元。从资产负债表来看，Globus Medical, Inc.总负债10.17亿美元，其中短期债务4.49亿美元，资产负债比为5.01，流动比率为2.52。机构评级：截至2024年11月11日，当前有13家机构对Globus Medical, Inc.目标价做出预测，其中目标均价为90.54美元，其中最低目标价为80.00美元，最高目标价为100.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000248abb363cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000248abb363cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GMED"],"gpt_icon":0},{"id":"1135819053","title":"异动解读 | 骨科医疗器械商Globus Medical第三季度业绩亮眼 股价盘前大涨12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135819053","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135819053?lang=zh_cn&edition=full","pubTime":"2024-11-06 17:48","pubTimestamp":1730886505,"startTime":"0","endTime":"0","summary":"医疗器械公司Globus Medical Inc.期周一股价盘前大涨12.46%,主因其第三季度业绩和全年预期均超出市场预期。财报显示,Globus Medical第三季度调整后每股收益为0.83美元,高于分析师预期的0.65美元。公司第三季度收入达到6.257亿美元,同比增长63.1%,也超过了分析师预测的6.0471亿美元。公司称,第三季度业绩出色主要得益于近期收购医疗器械公司NuVasive。凭借第三季度的出色表现,Globus Medical上调了2024财年的每股收益指引至2.90-3.00美元,高于此前指引2.80-2.90美元,也超过了华尔街2.85美元的共识预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GMED"],"gpt_icon":0},{"id":"1135035860","title":"异动解读 | 医疗器械巨头Globus Medical第三季度业绩超预期 股价盘后大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1135035860","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135035860?lang=zh_cn&edition=full","pubTime":"2024-11-06 15:38","pubTimestamp":1730878725,"startTime":"0","endTime":"0","summary":"为全球骨骼肌肉健康解决方案领军者Globus Medical Inc.(纽约证券交易所代码:GMED)周一盘后股价大涨9.55%,主因其2024年第三季度财报超乎市场预期。\n\n财报显示,第三季度Globus Medical调整后每股收益为0.83美元,远高于分析师预期的0.65美元。公司营收达6.257亿美元,同比大增63.1%,也超过华尔街预测的6.0471亿美元。\n\n公司表示,业绩出色主要得益于收购竞争对手NuVasive公司、脊柱产品销量增长强劲,以及使能技术产品及服务销售表现亮眼。数据显示,报告期内Globus Medical在美国和国际市场的销售分别同比增长60.3%和74.8%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GMED"],"gpt_icon":0},{"id":"1158104370","title":"异动解读 | Globus Medical第三季度业绩超预期 全年指引上调 盘后股价大涨9.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=1158104370","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158104370?lang=zh_cn&edition=full","pubTime":"2024-11-06 15:08","pubTimestamp":1730876910,"startTime":"0","endTime":"0","summary":"医疗器械公司Globus Medical Inc.周一盘后股价大涨9.55%,主要得益于公司公布的2024年第三季度业绩及全年指引远超市场预期。据财报显示,Globus Medical第三季度调整后每股收益为0.83美元,高于分析师预期的0.65美元,也高于去年同期的0.57美元。公司第三季度收入达到6.257亿美元,同比增长63.1%,也超过了分析师预测的6.0471亿美元。凭借第三季度的出色表现,Globus Medical上调了2024财年的每股收益指引至2.90-3.00美元,高于此前的2.80-2.90美元预期,也超过了华尔街2.85美元的共识预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GMED"],"gpt_icon":0},{"id":"1108039680","title":"异动解读 | Globus Medical 2024第三季度业绩超预期,股价盘后大涨 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1108039680","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108039680?lang=zh_cn&edition=full","pubTime":"2024-11-06 07:41","pubTimestamp":1730850070,"startTime":"0","endTime":"0","summary":"医疗器械公司Globus Medical Inc.(纽约证券交易所代码:GMED)周一(11月5日)盘后股价大涨9.55%,主要得益于公布的第三季度业绩和全年展望超出市场预期。\n\n财报显示,Globus Medical第三季度调整后每股收益为0.83美元,高于分析师预期的0.65美元。公司第三季度收入达到6.257亿美元,同比增长63.1%,也超过了分析师预测的6.0471亿美元。\n\n公司称,第三季度业绩出色主要得益于收购NuVasive公司,以及旗下脊柱产品销售和使能技术产品及服务销量的大幅增长。报告期内,美国市场净销售额同比增长60.3%,国际市场净销售额更是跃升74.8%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GMED"],"gpt_icon":0},{"id":"1197337465","title":"Globus Medical第三季度业绩强劲并上调指引，盘后股价上涨10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1197337465","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197337465?lang=zh_cn&edition=full","pubTime":"2024-11-06 07:36","pubTimestamp":1730849805,"startTime":"0","endTime":"0","summary":"肌肉骨骼解决方案公司 $Globus Medical Inc$  的股价在报告第三季度盈利超出分析师预期并上调全年指引后跃升7.4%。\"我们的第三季度业绩反映了我们业务的持续强劲，\"总裁兼首席执行官Dan Scavilla表示。\"Globus Medical上调了2024财年的每股收益指引至2.90-3.00美元，高于此前的2.80-2.90美元预期，也超过了华尔街2.85美元的共识预期。公司全球净销售额的增长主要由NuVasive的加入推动，以及脊柱产品销售和使能技术产品及服务的销量增加。","market":"us","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Globus Medical第三季度业绩强劲并上调指引","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GMED"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.globusmedical.com","stockEarnings":[{"period":"1week","weight":0.0169},{"period":"1month","weight":-0.0373},{"period":"3month","weight":-0.0176},{"period":"6month","weight":0.577},{"period":"1year","weight":0.1851},{"period":"ytd","weight":-0.0011}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Globus Medical, Inc.于2003年3月在特拉华州注册成立。作为一家医疗器械生产公司，Globus完全专注于其产品的设计、开发以及其商业化，其中这些产品能促进有脊柱疾病患者康复。Globus的产品分为两类，即创新融合类和颠覆性科技类。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.02965},{"month":2,"riseRate":0.714286,"avgChangeRate":-0.00268},{"month":3,"riseRate":0.5,"avgChangeRate":0.003416},{"month":4,"riseRate":0.538462,"avgChangeRate":0.002495},{"month":5,"riseRate":0.538462,"avgChangeRate":0.018358},{"month":6,"riseRate":0.461538,"avgChangeRate":0.006857},{"month":7,"riseRate":0.615385,"avgChangeRate":0.006966},{"month":8,"riseRate":0.615385,"avgChangeRate":0.009259},{"month":9,"riseRate":0.357143,"avgChangeRate":-0.019065},{"month":10,"riseRate":0.714286,"avgChangeRate":0.032586},{"month":11,"riseRate":0.642857,"avgChangeRate":0.064705},{"month":12,"riseRate":0.714286,"avgChangeRate":0.030327}],"exchange":"NYSE","name":"Globus Medical Inc","nameEN":"Globus Medical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Globus Medical Inc(GMED)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Globus Medical Inc(GMED)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Globus Medical Inc,GMED,Globus Medical Inc股票,Globus Medical Inc股票老虎,Globus Medical Inc股票老虎国际,Globus Medical Inc行情,Globus Medical Inc股票行情,Globus Medical Inc股价,Globus Medical Inc股市,Globus Medical Inc股票价格,Globus Medical Inc股票交易,Globus Medical Inc股票购买,Globus Medical Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Globus Medical Inc(GMED)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Globus Medical Inc(GMED)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}